| Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study C Fabiani, A Vitale, G Emmi, G Lopalco, L Vannozzi, S Guerriero, ... Clinical rheumatology 36, 191-197, 2017 | 144 | 2017 |
| Efficacy and safety of adalimumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study C Fabiani, A Vitale, G Emmi, L Vannozzi, G Lopalco, S Guerriero, ... Clinical rheumatology 36, 183-189, 2017 | 113 | 2017 |
| A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center … A Vitale, A Insalaco, P Sfriso, G Lopalco, G Emmi, M Cattalini, R Manna, ... Frontiers in pharmacology 7, 380, 2016 | 94 | 2016 |
| Cytokine signatures in mucocutaneous and ocular behcet’s disease G Lopalco, OM Lucherini, A Lopalco, V Venerito, C Fabiani, B Frediani, ... Frontiers in Immunology 8, 200, 2017 | 76 | 2017 |
| Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study J Sota, A Vitale, A Insalaco, P Sfriso, G Lopalco, G Emmi, M Cattalini, ... Clinical Rheumatology 37, 2233-2240, 2018 | 75 | 2018 |
| Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis GM Tosi, J Sota, A Vitale, D Rigante, G Emmi, G Lopalco, S Guerriero, ... Clin Exp Rheumatol 37 (4), 680-3, 2019 | 70 | 2019 |
| Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study C Fabiani, A Vitale, I Orlando, J Sota, M Capozzoli, R Franceschini, ... Internal and emergency medicine 12, 947-955, 2017 | 69 | 2017 |
| Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational … C Fabiani, A Vitale, D Rigante, G Emmi, A Bitossi, G Lopalco, J Sota, ... Clinical rheumatology 38, 407-415, 2019 | 68 | 2019 |
| Transepithelial iontophoresis versus standard corneal collagen cross-linking: 1-year results of a prospective clinical study P Vinciguerra, V Romano, P Rosetta, EF Legrottaglie, R Piscopo, ... Journal of Refractive Surgery 32 (10), 672-678, 2016 | 68 | 2016 |
| Adalimumab‐based treatment versus disease‐modifying antirheumatic drugs for venous thrombosis in Behçet's syndrome: A retrospective study of seventy patients with vascular … G Emmi, A Vitale, E Silvestri, M Boddi, M Becatti, C Fiorillo, C Fabiani, ... Arthritis & Rheumatology 70 (9), 1500-1507, 2018 | 67 | 2018 |
| The presence of uveitis is associated with a sustained response to the interleukin (IL)-1 inhibitors anakinra and canakinumab in Behçet’s disease C Fabiani, A Vitale, D Rigante, G Emmi, G Lopalco, G Di Scala, J Sota, ... Ocular immunology and inflammation 28 (2), 298-304, 2020 | 65 | 2020 |
| Rapid and sustained efficacy of golimumab in the treatment of multirefractory uveitis associated with Behçet’s disease C Fabiani, J Sota, D Rigante, A Vitale, G Emmi, L Vannozzi, ... Ocular Immunology and Inflammation 27 (1), 58-63, 2019 | 65 | 2019 |
| Psoriasis and psoriatic arthritis-related uveitis: different ophthalmological manifestations and ocular inflammation features A Abbouda, I Abicca, C Fabiani, N Scappatura, P Peña-García, R Scrivo, ... Seminars in ophthalmology 32 (6), 715-720, 2017 | 62 | 2017 |
| Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study A Vitale, G Emmi, G Lopalco, S Gentileschi, E Silvestri, C Fabiani, ... Clinical rheumatology 36, 451-455, 2017 | 62 | 2017 |
| Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome L Cantarini, A Vitale, LL Sicignano, G Emmi, E Verrecchia, I Patisso, ... Frontiers in Immunology 8, 1018, 2017 | 61 | 2017 |
| Cumulative retention rate of adalimumab in patients with Behçet’s disease-related uveitis: a four-year follow-up study C Fabiani, J Sota, A Vitale, D Rigante, G Emmi, L Vannozzi, D Bacherini, ... British Journal of Ophthalmology 102 (5), 637-641, 2018 | 59 | 2018 |
| Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: A multicenter retrospective observational study G Lopalco, G Emmi, S Gentileschi, S Guerriero, A Vitale, E Silvestri, ... Modern rheumatology 27 (6), 1031-1035, 2017 | 54 | 2017 |
| Ten-year retention rate of infliximab in patients with Behçet’s disease-related uveitis C Fabiani, J Sota, A Vitale, G Emmi, L Vannozzi, D Bacherini, G Lopalco, ... Ocular immunology and inflammation 27 (1), 34-39, 2019 | 53 | 2019 |
| Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease A Vitale, G Emmi, G Lopalco, C Fabiani, S Gentileschi, E Silvestri, ... Clinical rheumatology 36, 2063-2069, 2017 | 51 | 2017 |
| Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art C Fabiani, A Vitale, G Lopalco, F Iannone, B Frediani, L Cantarini Clinical rheumatology 35, 2631-2638, 2016 | 49 | 2016 |
